Could self-management challenge pharmacotherapy as a longterm treatment for uncomplicated lower urinary tract symptoms?

被引:9
作者
Brown, CT
Emberton, M
机构
[1] Royal Coll Surgeons England, Clin Effectiveness Unit, London WC2A 3PE, England
[2] Inst Urol & Nephrol, London, England
关键词
LUTS; BPH; self-management; pharmacotherapy; watchful waiting;
D O I
10.1097/00042307-200401000-00002
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review This review highlights the lifestyle and behavioural management strategies (self-management) available to men with lower urinary tract symptoms. Recent findings Pharmacotherapy has evolved considerably over the last decade and now most men with lower urinary tract symptoms are treated at some point with either single or combined therapy. However, recent studies reporting the longer term usage of pharmacotherapy have shown significantly high rates of discontinuation due to patient compliance, treatment ineffectiveness, side effects and patient choice. Not all these men will require or desire surgery. For those with bothersome symptoms self-management may be an effective strategy. Self-management interventions include education, reassurance, fluid management, caffeine avoidance, rescheduling concurrent medications and bladder retraining. As in other chronic disease areas such as diabetes and arthritis for which self-management is well established, lifestyle and behavioural interventions for men with lower urinary tract symptoms aim to allow the patient some day-to-day control over their symptoms. These interventions have been shown to be in wide use in the UK without good quality supporting evidence, suggesting that they are thought to be safe and effective. Summary Self-management (lifestyle and behavioural) interventions provide men with some control over their symptoms, their role as either a primary treatment strategy or to augment pharmacotherapy has yet to be defined.
引用
收藏
页码:7 / 12
页数:6
相关论文
共 51 条
[1]   NEW WORDS FOR OLD - LOWER URINARY-TRACT SYMPTOMS FOR PROSTATISM [J].
ABRAMS, P .
BRITISH MEDICAL JOURNAL, 1994, 308 (6934) :929-930
[2]  
Abrams P, 1996, SCAND J UROL NEPHROL, V30, P47
[3]  
ABRAMS P, 2003, J UROL S4, V167, P266
[4]   The progression of benign prostatic hyperplasia: Examining the evidence and determining the risk [J].
Anderson, JB ;
Roehrborn, CG ;
Schalken, JA ;
Emberton, M .
EUROPEAN UROLOGY, 2001, 39 (04) :390-398
[5]  
Bandura A., 1991, Neurobiology of learning, emotion, and affect, VIV, P229, DOI DOI 10.4135/9781412952576.N182
[6]   PATIENT REACTIONS TO A PROGRAM DESIGNED TO FACILITATE PATIENT PARTICIPATION IN TREATMENT DECISIONS FOR BENIGN PROSTATIC HYPERPLASIA [J].
BARRY, MJ ;
FOWLER, FJ ;
MULLEY, AG ;
HENDERSON, JV ;
WENNBERG, JE .
MEDICAL CARE, 1995, 33 (08) :771-782
[7]   The fear of prostate cancer in men with lower urinary tract symptoms: should symptomatic men be screened? [J].
Brown, CT ;
O'Flynn, E ;
Van der Meulen, J ;
Newman, S ;
Mundy, AR ;
Emberton, M .
BJU INTERNATIONAL, 2003, 91 (01) :30-32
[8]   Lifestyle and behavioural interventions for men on watchful waiting with uncomplicated lower urinary tract symptoms: a national multidisciplinary survey [J].
Brown, CT ;
Van Der Meulen, J ;
Mundy, AR ;
Emberton, M .
BJU INTERNATIONAL, 2003, 92 (01) :53-57
[9]  
Bryant Charmaine M, 2002, Br J Nurs, V11, P560
[10]   Influence of behavior modification on overactive bladder [J].
Burgio, KL .
UROLOGY, 2002, 60 (5A) :72-76